Aliskiren promotes atrial fibrillation in an experimental whole-heart model

被引:0
|
作者
Ellermann, C. [1 ]
Mittelstedt, A. [1 ]
Eckardt, L. [1 ]
Frommeyer, G. [1 ]
机构
[1] Univ Hosp Munster, Dept Cardiovasc Med, Div Electrophysiol, Munster, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P2871
引用
收藏
页码:601 / 602
页数:2
相关论文
共 50 条
  • [21] A WHOLE-HEART MODEL INCORPORATING MYOCARDIAL ANISOTROPY
    LORANGE, M
    GULRAJANI, RM
    DEGUISE, J
    FORTIER, P
    PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4, 1988, : 195 - 195
  • [22] Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation
    Satoh, Akira
    Niwano, Shinichi
    Niwano, Hiroe
    Kishihara, Jun
    Aoyama, Yuya
    Oikawa, Jun
    Fukaya, Hidehira
    Tamaki, Hideaki
    Ako, Junya
    HEART AND VESSELS, 2017, 32 (01) : 90 - 100
  • [23] Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation
    Akira Satoh
    Shinichi Niwano
    Hiroe Niwano
    Jun Kishihara
    Yuya Aoyama
    Jun Oikawa
    Hidehira Fukaya
    Hideaki Tamaki
    Junya Ako
    Heart and Vessels, 2017, 32 : 90 - 100
  • [24] Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia
    Gerrit Frommeyer
    Henning von der Ahe
    Benedict Brücher
    Dirk G. Dechering
    Philipp S. Lange
    Florian Reinke
    Kristina Wasmer
    Julia Köbe
    Christian Pott
    Gerold Mönnig
    Lars Eckardt
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2016, 389 : 1073 - 1080
  • [25] Low proarrhythmic potential of citalopram and escitalopram in contrast to haloperidol in an experimental whole-heart model
    Frommeyer, Gerrit
    Bruecher, Benedict
    von der Ahe, Henning
    Kaese, Sven
    Dechering, Dirk G.
    Kochhaeuser, Simon
    Bogossian, Harilaos
    Milberg, Peter
    Eckardt, Lars
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 788 : 192 - 199
  • [26] Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia
    Frommeyer, Gerrit
    von der Ahe, Henning
    Bruecher, Benedict
    Dechering, Dirk G.
    Lange, Philipp S.
    Reinke, Florian
    Wasmer, Kristina
    Koebe, Julia
    Pott, Christian
    Moennig, Gerold
    Eckardt, Lars
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (10) : 1073 - 1080
  • [27] Proarrhythmic potential of metoclopramide in a sensitive whole-heart model
    Wolfes, Julian
    Ellermann, Christian
    Burde, Sophie
    Fehr, Michael
    Eckardt, Lars
    Frommeyer, Gerrit
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 (06) : 741 - 746
  • [28] Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome
    Frommeyer, Gerrit
    Ellermann, Christian
    Dechering, Dirk G.
    Kochhaeuser, Simon
    Boegeholz, Nils
    Guener, Fatih
    Leitz, Patrick
    Pott, Christian
    Eckardt, Lars
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (10) : 1214 - 1219
  • [29] A training whole-heart model for simulating propagation and ECG patterns
    Pfeifer, B.
    Seger, M.
    Hanser, F.
    Hintermueller, C.
    Fischer, G.
    Muehlthaler, H.
    Tilg, B.
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2007, 2 (04) : 323 - 330
  • [30] Divergent antiarrhythmic effects of the polyphenols resveratrol and piceatannol in an experimental whole-heart model of long QT syndrome
    Ellermann, C.
    Wolfes, J.
    Frommeyer, G.
    Eckardt, L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 578 - 578